Tales from opposite corners of the world: Emergency department opt-out testing: A cost-effective route to earlier HIV and Hepatitis diagnosis in Australia and Germany
Australia and Germany have both made progress toward HIV and viral hepatitis elimination targets, yet a significant share of infections remains undiagnosed. These levels of undiagnosed infection indicate that standard blood-borne virus (BBV) testing approaches are not sufficient to meet public health goals. Emergency department opt-out testing European and US studies demonstrate the cost-effectiveness and Read More >
When will the UK achieve HIV transmission elimination? Modelling the impact of current HIV prevention efforts on progress towards the 2030 elimination goal
In 2019, the previous UK government set the ambitious target of eliminating HIV transmission within the UK by 2030. While great progress has been made in HIV prevention and treatment in the UK, with England reaching the UNAIDS 95-95-95 target in 20231, past evidence suggested that the goal of ‘elimination’ by 2030 is unlikely to Read More >
Cost-effectiveness and impact of five different point of care strategies to preserve last line treatment for gonorrhoea
Modelling cost-effectiveness of multipathogen POC tests for sexually transmitted infections
Assessing the impact of point-of-care testing for influenza and respiratory syncytial virus in children admitted to hospital
Exploring HCV eradication through diagnosis and treatment strategies
Cost-effectiveness of antimicrobial resistance point-of-care testing for optimising gonorrhoea treatment
Point-of-care tests for infectious diseases: Barriers to implementation across three London teaching hospitals
Estimating the clinical impact and costs of implementing a point of care test for influenza A/B and respiratory syncytial virus on an acute paediatric hospital inpatient ward
A rapid influenza test in hospitals could avoid unnecessary paediatric isolation bed days and save costs
